Endocytosis of HIV-1 activates plasmacytoid dendritic cells via toll-like receptor-viral RNA interactions

被引:516
作者
Beignon, AS
McKenna, K
Skoberne, M
Manches, O
DaSilva, I
Kavanagh, DG
Larsson, M
Gorelick, RJ
Lifson, JD
Bhardwaj, N
机构
[1] NYU, Sch Med, New York, NY 10016 USA
[2] Massachusetts Gen Hosp, Partners AIDS Res Ctr, Boston, MA 02114 USA
[3] Harvard Univ, Sch Med, Boston, MA 02115 USA
[4] NCI, AIDS Vaccine Program, Sci Applicat Int Corp, Frederick Inc, Frederick, MD 21701 USA
基金
英国惠康基金;
关键词
D O I
10.1172/JCI26032
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
HIV-1 directly activates human plasmacytoid DCs (pDCs) by upregulating the expression of costimulatory and MHC molecules and maturation markers, increasing T cell stimulatory activity, and inducing the production of type I interferons and TNF-alpha. A consequence of this activation is the bystander maturation of myeloid DCs and overall enhancement of antigen-presenting function. However, little is known about the mechanism(s) of pDC activation by HIV-1. Here we demonstrate by in vitro studies that IFN-alpha production by pDC in response to HIV-1 requires at least 2 interactions between the cell and virus. Initially, envelope-CD4 interactions mediate endocytosis of HIV-1, as demonstrated through the use of inhibitors of binding, fusion, endocytosis, and endosomal acidification. Subsequently, endosomally delivered viral nucleic acids, particularly RNA, stimulate pDCs through TLRs, as activation is reproduced with purified genomic RNA but not viral RNA packaging-deficient HIV-1 and blocked with different inhibitory TLR ligands. Finally, by using genetic complementation, we show that TLR7 is the likely primary target. Viral RNA rather than DNA in early retrotranscripts appears to be the active factor in HIV-1 that induces IFN-alpha secretion by pDCs. Since the decline in pDCs in chronic HIV-1 infection is associated with high viral loads and opportunistic infections, exploiting this natural adjuvant activity of HIV-1 RNA might be useful in the development of vaccines for the prevention of AIDS.
引用
收藏
页码:3265 / 3275
页数:11
相关论文
共 86 条
  • [41] JURK M, 2004, 12 INT C IMM 4 ANN C, V27, P2333
  • [42] Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens
    Kadowaki, N
    Ho, S
    Antonenko, S
    Malefyt, RD
    Kastelein, RA
    Bazan, F
    Liu, YJ
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 194 (06) : 863 - 869
  • [43] WHY IS CPG SUPPRESSED IN THE GENOMES OF VIRTUALLY ALL SMALL EUKARYOTIC VIRUSES BUT NOT IN THOSE OF LARGE EUKARYOTIC VIRUSES
    KARLIN, S
    DOERFLER, W
    CARDON, LR
    [J]. JOURNAL OF VIROLOGY, 1994, 68 (05) : 2889 - 2897
  • [44] Spontaneous formation of nucleic acid-based nanoparticles is responsible for high interferon-α induction by CpG-A in plasmacytoid dendritic cells
    Kerkmann, M
    Costa, LT
    Richter, C
    Rothenfusser, S
    Battiany, J
    Hornung, V
    Johnson, J
    Englert, S
    Ketterer, T
    Heckl, W
    Thalhammer, S
    Endres, S
    Hartmann, G
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (09) : 8086 - 8093
  • [45] Is there enough gp120 in the body fluids of HIV-1-infected individuals to have biologically significant effects?
    Klasse, PJ
    Moore, JP
    [J]. VIROLOGY, 2004, 323 (01) : 1 - 8
  • [46] TL-139-dependent recognition of MCMV by IPC and DC generates coordinated cytokine responses that activate antiviral NK cell function
    Krug, A
    French, AR
    Barchet, W
    Fischer, JAA
    Dzionek, A
    Pingel, JT
    Orihuela, MM
    Akira, S
    Yokoyama, WM
    Colonna, M
    [J]. IMMUNITY, 2004, 21 (01) : 107 - 119
  • [47] Herpes simplex virus type 1 activates murine natural interferon-producing cells through toll-like receptor 9
    Krug, A
    Luker, GD
    Barchet, W
    Leib, DA
    Akira, S
    Colonna, M
    [J]. BLOOD, 2004, 103 (04) : 1433 - 1437
  • [48] Krug A, 2001, EUR J IMMUNOL, V31, P3026, DOI 10.1002/1521-4141(2001010)31:10<3026::AID-IMMU3026>3.0.CO
  • [49] 2-H
  • [50] HIV-1 entry inhibitor entrances
    Kuhmann, SE
    Moore, JP
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 2004, 25 (03) : 117 - 120